Log in to save to my catalogue

Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in th...

Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_343115

Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer disease

About this item

Full title

Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer disease

Publisher

England: John Wiley & Sons, Inc

Journal title

European journal of neurology, 2024-12, Vol.31 (12), p.e16255-n/a

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background and purpose
This study was undertaken to compare the performance of plasma p‐tau181 with that of [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in the identification of early biological Alzheimer disease (AD).
Methods
We included 533 cognitively impaired participants from the Alzheimer's Disease Neuroimaging In...

Alternative Titles

Full title

Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_343115

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_343115

Other Identifiers

ISSN

1351-5101,1468-1331

E-ISSN

1468-1331

DOI

10.1111/ene.16255

How to access this item